Related Experiment Video
Updated: May 28, 2026
04:40
Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
[The venous thromboembolic disease]
Gilberto Guzmán Valdivia-Gómez1
1Hospital General Regional Dr. Carlos McGregor Sánchez Navarro, Instituto Mexicano del Seguro Social, Distrito Federal, México. guzvaldi@yahoo.com
Revista Medica Del Instituto Mexicano Del Seguro Social
|October 11, 2011
Summary
Venous thromboembolic disease (VTD), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant health issue. Thromboprophylaxis is crucial for preventing VTD and improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Public Health
Context:
- Venous thromboembolic disease (VTD) encompasses deep vein thrombosis (DVT), post-thrombotic syndrome (PTS), and pulmonary embolism (PE).
- Thrombus formation, leading to VTD, results from abnormalities disrupting blood's liquid state, often linked to thrombophilias.
- Virchow's classification identifies stasis, endothelial damage, and hypercoagulable states as key factors in VTD development.
Purpose:
- To summarize the etiology, risk factors, and prevention strategies for venous thromboembolic disease.
- To highlight the significance of thromboprophylaxis in managing VTD and its complications.
Summary:
- VTD is a common condition involving thrombus formation in veins, primarily caused by thrombophilias affecting hemostasis.
- Risk factors include hospitalization, medical conditions, and surgeries, particularly orthopedic and vascular procedures on the legs.
- Despite asymptomatic DVTs in nearly 50% of cases, VTD can lead to PE and mortality, underscoring the need for prevention.
Impact:
- Thromboprophylaxis is the primary strategy to reduce DVT incidence and associated complications.
- Effective VTD prevention improves patient quality of life and offers economic benefits to healthcare systems.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...